FDA’s Poor Performance “Invites Catastrophe,” House Investigator Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Good public health response, poor regulatory oversight mark adulterated heparin episode, Nelson testifies.
You may also be interested in...
FDA Should Be Allowed To Schedule Foreign Inspections Based On Risk – CDER’s Woodcock
“Risk-based” may be code for doing the minimum because of underfunding, Rep. Dingell says.
FDA Should Be Allowed To Schedule Foreign Inspections Based On Risk – CDER’s Woodcock
“Risk-based” may be code for doing the minimum because of underfunding, Rep. Dingell says.
FDA Head Faces Grilling Over China’s Heparin
Lack of inspections “encouraged” bad drugs, lawmaker tells agency chief.